Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
WORKING PAPERS
April 11, 2024
POLICY PAPERS
April 15, 2024
CGD NOTES
April 08, 2024
WORKING PAPERS
April 04, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
WORKING PAPERS
April 02, 2024
Starting in 2001, duty-free access to U.S. markets under the African Growth and Opportunity Act (AGOA) led to a brief boom in African manufacturing exports, particularly apparel, which then fizzled in the face of unfettered Chinese competition after 2005. The looming expiration of AGOA—and eroding C...
WORKING PAPERS
February 08, 2024
While labor market impacts of refugees in low- and middle-income countries are commonly studied, public services like education could also be affected by mass arrivals. This paper examines the impact of Syrian refugees on the educational outcomes of Jordanians. Combining detailed household surveys w...
WORKING PAPERS
May 04, 2023
Many public policies create (perceived) winners and losers, but there is little evidence on whether redistribution can support new political economy equilibria that raise aggregate welfare. We study a Ugandan policy that redistributes 30 percent of foreign aid for refugees to Ugandans while allowing...
WORKING PAPERS
January 28, 2022
Providing patients with high-quality essential medicines requires a well-functioning procurement, distribution, and regulatory system. However, in many low- and lower-middle-income countries (LMICs), public sector supply chain performance is far from optimal, resulting in frequent stockouts at healt...
WORKING PAPERS
July 20, 2021
India lacks an authoritative estimate of the death toll from the COVID-19 pandemic. We report excess mortality estimates from three different data sources from the pandemic’s start through June 2021. Estimating COVID-deaths with statistical confidence may prove elusive. But all estimates suggest tha...
WORKING PAPERS
December 14, 2020
Between 2011 and 2016, the Affordable Medicines Facility-Malaria (AMFm) subsidy program substantially increased access to WHO prequalified artemisinin combination therapies (ACTs) through Africa’s private sector pharmacies and drug-sellers. While the program was rigorously and extensively evaluated,...